Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: Critical evaluation using whole-mount pathology as standard of reference Journal Article

   

Authors:	Vargas, H. A.; Hötker, A. M.; Goldman, D. A.; Moskowitz, C. S.; Gondo, T.; Matsumoto, K.; Ehdaie, B.; Woo, S.; Fine, S. W.; Reuter, V. E.; Sala, E.; Hricak, H.
Article Title:	Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: Critical evaluation using whole-mount pathology as standard of reference
Abstract:	To evaluate the recommendations for multiparametric prostate MRI (mp-MRI) interpretation introduced in the recently updated Prostate Imaging Reporting and Data System version 2 (PI-RADSv2), and investigate the impact of pathologic tumour volume on prostate cancer (PCa) detectability on mpMRI. This was an institutional review board (IRB)-approved, retrospective study of 150 PCa patients who underwent mp-MRI before prostatectomy; 169 tumours a parts per thousand yen0.5-mL (any Gleason Score [GS]) and 37 tumours < 0.5-mL (GS a parts per thousand yen4+3) identified on whole-mount pathology maps were located on mp-MRI consisting of T2-weighted imaging (T2WI), diffusion-weighted (DW)-MRI, and dynamic contrast-enhanced (DCE)-MRI. Corresponding PI-RADSv2 scores were assigned on each sequence and combined as recommended by PI-RADSv2. We calculated the proportion of PCa foci on whole-mount pathology correctly identified with PI-RADSv2 (dichotomized scores 1-3 vs. 4-5), stratified by pathologic tumour volume. PI-RADSv2 allowed correct identification of 118/125 (94 %; 95 %CI: 90-99 %) peripheral zone (PZ) and 42/44 (95 %; 95 %CI: 89-100 %) transition zone (TZ) tumours a parts per thousand yen0.5 mL, but only 7/27 (26 %; 95 %CI: 10-42 %) PZ and 2/10 (20 %; 95 %CI: 0-52 %) TZ tumours with a GS a parts per thousand yen4+3, but < 0.5 mL. DCE-MRI aided detection of 4/125 PZ tumours a parts per thousand yen0.5 mL and 0/27 PZ tumours < 0.5 mL. PI-RADSv2 correctly identified 94-95 % of PCa foci a parts per thousand yen0.5 mL, but was limited for the assessment of GS a parts per thousand yen4+3 tumours a parts per thousand currency sign0.5 mL. DCE-MRI offered limited added value to T2WI+DW-MRI. aEuro cent PI-RADSv2 correctly identified 95 % of PCa foci a parts per thousand yen0.5 mL aEuro cent PI-RADSv2 was limited for the assessment of GS a parts per thousand yen4+3 tumours a parts per thousand currency sign0.5 mL aEuro cent DCE-MRI offered limited added value to T2WI+DW-MRI.
Keywords:	diffusion; prostate cancer; mri; dce; pi-rads
Journal Title:	European Radiology
Volume:	26
Issue:	6
ISSN:	0938-7994
Publisher:	Springer
Date Published:	2016-06-01
Start Page:	1606
End Page:	1612
Language:	English
ACCESSION:	WOS:000376100100011
DOI:	10.1007/s00330-015-4015-6
PROVIDER:	wos
PMCID:	PMC4803633
PUBMED:	26396111
Notes:	Article -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/94833